The U.S. Food and Drug Administration
approved the expanded use of GSK s respiratory syncytial
virus vaccine on Friday in adults aged between 50 and 59, making
it the first shot endorsed for that age.
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
EMA's recommendation for the French firm's vaccine Ixchiq comes as the mosquito-borne disease, for which no approved drugs exist, has been spreading due to climate change. While environmental conditions in Europe are not yet favorable for chikungunya, the European Centre for Disease Prevention and Control (ECDC) warns of potential risks, citing the influx of potentially infected travelers and a population that could be susceptible to it.
Novartis leukemia drug more effective than older treatments in trial yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Dengue cases in Americas surpass last year's record high, WHO says marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.